UBS Maintains Neutral on Stryker, Raises Price Target to $370
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Danielle Antalffy maintains a Neutral rating on Stryker (NYSE:SYK) and raises the price target from $366 to $370.

October 30, 2024 | 2:11 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
UBS has maintained a Neutral rating on Stryker but increased the price target slightly from $366 to $370, indicating a modestly positive outlook.
The Neutral rating suggests UBS does not expect significant short-term movement in Stryker's stock price. However, the slight increase in the price target to $370 indicates a modestly positive outlook, suggesting potential for slight appreciation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100